Forever young: the firms keeping people active

WHO IS WINNING BETWEEN NOVO-NORDISK AND ELI LILLY?

It could take a long time to reverse decades of lagging behind the US

That figure could rise further. A wave of cutting-edge canine science is sweeping the globe, with everything from the Dog Aging Project’s 50,000-pet study, to biotech firms racing to develop anti-agei

You might think that by the time you reach your 70s, most of your life’s financial decisions are behind you, but actually this decade is a hugely important one, and 75 is a milestone that requires spe

Andrew van Sickle: Shall we start with an overview of your fund? Daniel Avigad: The TM Lansdowne European Special Situations Fund is a long-only, mid- to large cap-focused Europe ex-UK fund. We concen

THE COMPANIES BOOSTING RETURNS TO SHAREHOLDERS